An inventory of European data sources for the long-term safety evaluation of methylphenidate

European Child and Adolescent Psychiatry

Volumn 22, Issue 10, 2013, Pages 605-618

  Murray, Macey L ^a   Insuk, Suppachai ^a   Banaschewski, Tobias ^b   Neubert, Antje C ^a,c   McCarthy, Suzanne ^d,e   Buitelaar, Jan K ^f   Coghill, David ^g   Dittmann, Ralf W ^b   Konrad, Kerstin ^h   Panei, Pietro ⁱ   Rosenthal, Eric ^j   Sonuga Barke, Edmund J ^k,m   Wong, Ian C K ^a,l  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d UNIVERSITY COLLEGE CORK   (Ireland)

^e University College Cork   (Ireland)

^f RADBOUD UNIVERSITY   (Netherlands)

^g UNIVERSITY OF DUNDEE   (United Kingdom)

^h UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

ⁱ ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^j ST THOMAS HOSPITAL   (United Kingdom)

^k UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^l UNIVERSITY OF HONG KONG   (Hong Kong)

^m GHENT UNIVERSITY   (Belgium)

more..

Author keywords

Attention deficit hyperactivity disorder (ADHD); Database(s); Drug safety; Methylphenidate; Paediatric

Indexed keywords

METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DATA ANALYSIS SOFTWARE; DATA BASE; DISEASE REGISTRY; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; ELECTRONIC MEDICAL RECORD; EUROPEAN UNION; FEASIBILITY STUDY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHARMACOEPIDEMIOLOGY; PRIMARY MEDICAL CARE;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; DATABASES, FACTUAL; EUROPE; HUMANS; METHYLPHENIDATE; PHARMACOVIGILANCE; REGISTRIES; SAFETY;

EID: 84885590372     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-013-0386-x     Document Type: Article

References (40)

1. Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE (2000) Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 48(1):9-20
2. Graham J, Coghill D (2008) Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management. CNS Drugs 22(3):213-237
3. Graham J, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Döpfner M, Hamilton R, Hollis C, Holtmann M, Hulpke-Wette M, Lecendreux M, Rosenthal E, Rothenberger A, Santosh P, Sergeant J, Simonoff E, Sonuga-Barke E, Wong IC, Zuddas A, Steinhausen HC, Taylor E, European Guidelines Group (2011) European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry 20(1):17-37
4. Nissen SE (2006) ADHD drugs and cardiovascular risk. N Engl J Med 354(14):1445-1448
5. European Medicines Agency (2007) PRESS RELEASE: Meeting highlights from the Committee for Medicinal Products for Human Use, 16-19 July 2007. London: European Medicines Agency. http://www.emea.europa.eu/docs/en-GB/document- library/Press-release/2009/12/WC500017068.pdf. Accessed 12 September 2012
6. European Medicines Agency (2009) European Medicines Agency makes recommendations for safer use of Ritalin and other methylphenidate-containing medicines in the EU. London: European Medicines Agency. http://www.ema.europa. eu/docs/en-GB/document-library/Press-release/2009/11/WC500014589.pdf (accessed 12/09/2012)
7. Neubert A, Sturkenboom MC, Murray ML, Verhamme KM, Nicolosi A, Giaquinto C, Ceci A, Wong IC (2008) Databases for pediatric medicine research in Europe-assessment and critical appraisal. Pharmacoepidemiol Drug Saf 17(12):1155-1167
8. European Medicines Agency (2005) Guideline on risk management systems for medicinal products for human use. European Medicines Agency, London
9. Gau C-S, Chen C-F, Gau SS-F (2010) The influence of using methylphenidate on the coming up of psychiatric disorders in children with ADHD. Pharmacoepidemiol Drug Saf 19(S1):S152-S153
10. McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC (2009) Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database. Drug Saf 32(11):1089-1096
11. Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA (2011) ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 365(20):1896-1904
12. Winterstein AG, Gerhard T, Kubilis P, Saidi A, Linden S, Crystal S, Zito J, Shuster JJ, Olfson M (2012) Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study. BMJ 345:e4627. doi: 10.1136/bmj.e4627
13. Hsia Y, Neubert A, Sturkenboom MC, Murray ML, Verhamme KM, Sen F, Giaquinto C, Ceci A, Wong IC, on behalf of the TEDDY Network of Excellence (2010) Comparison of antiepileptic drug prescribing in children in three European countries. Epilepsia 51(5):789-796
14. Sen EF, Verhamme KM, Neubert A, Hsia Y, Murray M, Felisi M, Giaquinto C, 't Jong GW, Picelli G, Baraldi E, Nicolosi A, Ceci A, Wong IC, Sturkenboom MC, on behalf of the TEDDY European Network of Excellence (2011) Assessment of pediatric asthma drug use in three European countries; a TEDDY study. Eur J Pediatr 170(1):81-92
15. Neubert A, Verhamme K, Murray ML, Picelli G, Hsia HF, Sen FE, Giaquinto C, Ceci A, Sturkenboom M, Wong ICK (2010) The prescribing of analgesics and non-steroidal anti-inflammatory drugs in paediatric primary care in the UK, Italy and the Netherlands. Pharmacol Res 62(3):243-248
16. Sturkenboom MC, Verhamme KM, Nicolosi A, Murray ML, Neubert A, Caudri D, Picelli G, Sen EF, Giaquinto C, Cantarutti L, Baiardi P, Felisi MG, Ceci A, Wong IC, TEDDY European Network of Excellence. (2008) Drug use in children: cohort study in three European countries. BMJ 337:a2245. doi: 10.1136/bmj.a2245
17. Anon (2010) Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK. Pharmacoepidemiol Drug Saf 19(S1):S1-S347
18. Schneeweiss S, Avorn J (2005) A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 58:323-337
19. Jaddoe VW, van Duijn CM, van der Heijden AJ, Mackenbach JP, Moll HA, Steegers EA, Tiemeier H, Uitterlinden AG, Verhulst FC, Hofman A (2010) The Generation R Study: design and cohort update. Eur J Epidemiol 25(11):823-841
20. Ghassabian A, Bongers-Schokking JJ, de Rijke YB, van Mil N, Jaddoe VW, de Muinck Keizer-Schrama SM, Hooijkaas H, Hofman A, Visser W, Roman GC, Visser TJ, Verhulst FC, Tiemeier H (2012) Maternal thyroid autoimmunity during pregnancy and the risk of attention deficit/hyperactivity problems in children: the Generation R Study. Thyroid 22(2):178-186. doi: 10.1089/thy.2011.0318
21. Cai B, Xu W, Bortnichak E, Watson D (2012) An algorithm to identify medical practices common to both the General Practice Research Database and The Health Improvement Network database. Pharmacoepidemiol Drug Saf 21:770-774
22. WHO Collaborating Centre for Drug Statistics Methodology. (2012) Anatomical Therapeutic Chemical classification system: structure and principles. http://www.whocc.no/atc-ddd-index/. Accessed 15 August 2012
23. European Pharmaceutical Marketing Research Association (2012). Anatomical Classification. http://www.ephmra.org/classification/anatomical-classification. aspx. Accessed 15 August 2012
24. World Health Organization. International Classification of Diseases (ICD). http://www.who.int/classifications/icd/en. Accessed 24 December 2012
25. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, Text Revision (DSM-IV-TR), 4th edn. American Psychiatric Association, Washington, DC
26. Cantwell DP (1996) Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 35(8):978-987. doi: 10.1097/00004583-199608000-00008
27. Rucklidge JJ, Tannock R (2002) Validity of the Brown ADD scales: an investigation in a predominantly inattentive ADHD adolescent sample with and without reading disabilities. J Atten Disord 5(3):155-164
28. Goodman R (1997) The Strengths and Difficulties Questionnaire: a Research Note. J Child Psychol Psychiatry 38:581-586
29. Panei P, Arcieri R, Bonati M, Bugarini M, Didoni A, Germinario E (2010) Safety of psychotropic drug prescribed for attention-deficit/hyperactivity disorder in Italy. Adverse Drug Reaction Bulletin 260:999-1002
30. Didoni A, Sequi M, Panei P, Bonati M (2011) One-year prospective follow-up of pharmacological treatment in children with attention-deficit/ hyperactivity disorder. Eur J Clin Pharmacol 67:1061-1067
31. Arcieri R, Germinario EAP, Bonati M, Masi G, Zuddas A, Vella S, Chiarotti F, Panei P, the Italian Attention-Deficit/Hyperactivity Disorder Regional Reference Centers (2012) Cardiovascular Measures in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Who Are New Users of Methylphenidate and Atomoxetine. J Child Adolesc Psychopharmacol 22:423-431
32. McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, Sayal K, de Soysa R, Taylor E, Williams T, Wong ICK (2009) Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry 194:273-277
33. McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong IC (2012) The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatrics 12(1):78 Epub
34. Kurth BM, Kamtsiuris P, Hölling H, Schlaud M, Dölle R, Ellert U et al (2008) The challenge of comprehensively mapping children's health in a nation-wide health survey: design of the German KiGGS-Study. BMC Public Health 8:196
35. Huss M, Hölling H, Kurth BM, Schlack R (2008) How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS). Eur Child Adolesc Psychiatry 17(Suppl 1):52-58
36. Ehrenstein V, Antonsen S, Pedersen L (2010) Existing data sources for clinical epidemiology: Aarhus University Prescription Database. Clin Epidemiol 2:273-279
37. WHO. (2012) International Classification of Primary Care, Second edition (ICPC-2). http://www.who.int/classifications/icd/adaptations/icpc2/en/index. html. Accessed 15 August 2012
38. Sturkenboom M, Nicolosi A, Cantarutti L, Mannino S, Picelli G, Scamarcia A, Giaquinto C, NSAIDs Paediatric Research Group (2005) Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics. Pediatrics 116:e26-e33
39. Lindemann C, Langner I, Kraut A, Banaschewski T et al (2012) Age-specific prevalence, incidence of new diagnoses and drug treatment of attention-deficit/hyperactivity disorder in Germany. J Child Adolesc Psychopharmacol 22:307-314
40. Coloma PM, Schuemie MJ, Trifirò G, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Giaquinto C, Corrao G, Pedersen L, van der Lei J, Sturkenboom M, EU-ADR Consortium (2011) Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf 20(1):1-11